Skip to content

Released Mar 30, 2015, after the close

10-Q filed Mar 31, 2015, 182 days after period end · 0001193125-15-112321

Q3 2014 · 10-Q
Revenue$100.99M+10.0% vs Q3 2013+0.0% vs Q2 2014
Net Income$452.00KN/M vs Q3 2013N/M vs Q2 2014
EPS Diluted$0.02N/M vs Q3 2013N/M vs Q2 2014
Gross Profit$75,726,000+13.5%
Operating Income$6,508,000N/M
Operating Cash Flowderived$18,092,000+1.8%
Free Cash Flowderived$12,906,000+15.6%
Margins · derived
Gross margin75.0%+2.3 pt vs Q3 2013
Operating margin6.4%+21.8 pt vs Q3 2013
Net margin0.4%+21.0 pt vs Q3 2013

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2014Q3 2013Q3 2012Q3 2011
Revenue$100.99M$91.81M$105.82M$111.51M
Net Income$452.00K-$18.84M$3.75M$10.08M
EPS Diluted$0.02-$1.04$0.19$0.54

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR